BIOMAT Database Logo BIOMAT Database Logo

[The human hematopoietic stem cell, normal and leukemic]. 1991

M Gabbianelli, and M Valtieri, and C Peschle
Laboratorio di Ematologia ed Oncologia, Istituto Superiore di Sanità, Roma.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis

Related Publications

M Gabbianelli, and M Valtieri, and C Peschle
Normal and leukemic CD34-negative human hematopoietic stem cells.
March 2001, Reviews in clinical and experimental hematology,
M Gabbianelli, and M Valtieri, and C Peschle
Interactions between hematopoietic growth factors in normal and leukemic stem cell differentiation.
January 1989, Annals of the New York Academy of Sciences,
M Gabbianelli, and M Valtieri, and C Peschle
Hox regulation of normal and leukemic hematopoietic stem cells.
May 2005, Current opinion in hematology,
M Gabbianelli, and M Valtieri, and C Peschle
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness.
June 2019, Nature communications,
M Gabbianelli, and M Valtieri, and C Peschle
The regulation of normal and leukemic hematopoietic stem cells by niches.
December 2012, Cancer microenvironment : official journal of the International Cancer Microenvironment Society,
M Gabbianelli, and M Valtieri, and C Peschle
The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell Function.
October 2011, Therapeutic advances in hematology,
M Gabbianelli, and M Valtieri, and C Peschle
Normal and leukemic stem cell niche interactions.
July 2019, Current opinion in hematology,
M Gabbianelli, and M Valtieri, and C Peschle
DNA polymerases in normal and leukemic human hematopoietic cells.
July 1974, Blood,
M Gabbianelli, and M Valtieri, and C Peschle
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells.
December 2009, Leukemia,
M Gabbianelli, and M Valtieri, and C Peschle
Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
August 2007, Stem cells (Dayton, Ohio),
Copied contents to your clipboard!